Saint Paul, MN, United States of America

Mark A Rustad


Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 45(Granted Patents)


Location History:

  • Afton, MN (US) (1987 - 1991)
  • Saint Paul, MN (US) (1979 - 1992)

Company Filing History:


Years Active: 1979-1992

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark A. Rustad

Introduction

Mark A. Rustad, an accomplished inventor based in Saint Paul, Minnesota, has made significant strides in the field of pharmaceuticals with a total of 14 patents to his name. His work primarily focuses on novel compounds that serve essential roles in medical treatments, particularly in inhibiting leukotriene biosynthesis and acting as antiallergic agents.

Latest Patents

Rustad's latest patents include innovative compounds such as substituted di-t-butylphenols. These compounds are characterized by being 2,6-di-t-butylphenols substituted in the 4 position by either a carbamyl or acylamino group, which further is modified by a group that includes an acidic substituent. These compounds are particularly highlighted for their pharmacological advantages, being useful as inhibitors of leukotriene biosynthesis and as antiallergic agents. Another notable patent features di-t-butylphenols, which are substituted in the 4 position by an alkoxy or benzyloxy group or a benzylthio group. These modifications allow for their effective use in medical applications, showcasing the versatility of Rustad's inventive contributions.

Career Highlights

Mark A. Rustad has built a career centered around research and innovation at Riker Laboratories Inc. Over the years, he has cultivated expertise in pharmaceutical formulations and therapeutic development, allowing him to contribute significantly to advancements in healthcare. His portfolio of 14 patents underscores his role as a key player in the scientific community focused on providing therapeutic solutions.

Collaborations

Throughout his career, Rustad has collaborated with notable colleagues such as Walton J. Hammar and Robert A. Scherrer. These partnerships have led to groundbreaking research and the successful development of effective pharmaceutical agents. Working alongside such talented individuals has allowed for the exchange of ideas and strategies that enhance the creative process in patentable inventions.

Conclusion

Mark A. Rustad stands out as a leading inventor in the pharmaceutical realm, with a significant number of patents that reflect his dedication to improving medical treatments. His innovative approaches and collaboration with industry professionals continue to make a positive impact in the field, further establishing his reputation as a formidable inventor and researcher.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…